» Articles » PMID: 32294559

Antimicrobial Photodynamic Therapy with Bixa Orellana Extract and Blue LED in the Reduction of Halitosis-A Randomized, Controlled Clinical Trial

Abstract

Background: This study aimed to evaluate the reduction of halitosis when using antimicrobial photodynamic therapy (aPDT) with Bixa orellana extract and blue light-emitting diode (LED).

Methods: Forty-four UNINOVE students or employees with a diagnosis of sulfide (H2S) ≥ 112 ppb in gas chromatography were selected. The patients were randomly divided in groups: Group 1 (n = 15): aPDT with annatto and LED; Group 2 (n = 14): tongue scraping; Group 3 (n = 15): tongue scraping and aPDT. For aPDT, a wasBixa orellana extract used in a concentration of 20 % w/v (Fórmula e Ação®, São Paulo, Brazil) on the tongue for 2 min, associated with a blue-violet LED (Valo Cordless Ultradent® Products, Inc., South Jordan, UT, USA) (395-480 nm). Six points were irradiated on the back of the tongue, at wavelength 395-480 nm for 20 s, energy of 9.6 J and radiant energy of 6.37 J/cm per point. The results were compared before, immediately after treatment and 7 days after. The Friedman test was used for the intragroup analysis and the Kruskal Wallis test for the intergroup analysis.

Results: In all groups, there was a difference between baseline and the value immediately after the treatment. In Groups 1 and 3, there was no difference between the baseline and the 7 days control.

Conclusion: There was an immediate reduction of halitosis, but the reduction was not maintained after 7days.

Citing Articles

Assessment of photodynamic therapy with annatto and led for the treatment of halitosis in mouth-breathing children: Randomized controlled clinical trial.

Bruno L, Mandetta A, Sobral A, Goncalves M, Santos E, Fossati A PLoS One. 2024; 19(9):e0307957.

PMID: 39226284 PMC: 11371243. DOI: 10.1371/journal.pone.0307957.


Short term effect of antimicrobial photodynamic therapy and probiotic L. salivarius WB21 on halitosis: A controlled and randomized clinical trial.

Motta P, Goncalves M, Gallo J, Sobral A, Motta L, Mayer M PLoS One. 2024; 19(7):e0297351.

PMID: 38954692 PMC: 11218947. DOI: 10.1371/journal.pone.0297351.


Evaluation of the Oral Microbiome before and after Treatments for Halitosis with Photodynamic Therapy and Probiotics-Pilot Study.

Motta P, Goncalves M, Gallo J, Sobral A, Motta L, Santos E Healthcare (Basel). 2024; 12(11).

PMID: 38891198 PMC: 11172044. DOI: 10.3390/healthcare12111123.


Antimicrobial photodynamic therapy with erythrosine and blue light on dental biofilm bacteria: study protocol for randomised clinical trial.

Goncalves M, Sobral A, Gallo J, Gimenez T, Ferri E, Ianello S BMJ Open. 2023; 13(9):e075084.

PMID: 37730405 PMC: 10510942. DOI: 10.1136/bmjopen-2023-075084.


Investigation on the effect of antimicrobial photodynamic therapy as an adjunct for management of deep caries lesions-study protocol for a randomized, parallel groups, controlled clinical trial.

Martins L, de Sena L, De Paula D, Feitosa V, Tempestini Horliana A, Porta Santos Fernandes K Trials. 2023; 24(1):165.

PMID: 36870982 PMC: 9985277. DOI: 10.1186/s13063-023-07181-8.